21.05

2.32% -0.50

After Hours: 21.05

Fortrea Holdings Inc (FTRE)

Overview News Price History Option Chain Financials Why FTRE Down? Discussions Forecast

Fortrea Holdings Inc stock is traded at $21.05, with a volume of 414.93K. It is down -2.32% in the last 24 hours and up +18.73% over the past month. Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Previous Close:

$21.55

Open:

$21.6

24h Volume:

414.93K

Relative Volume:

0.29

Market Cap:

$1.89B

Revenue:

$2.98B

Net Income/Loss:

$-300.00M

P/E Ratio:

16.08

EPS:

1.3088

Net Cash Flow:

$225.00M

1W Performance:

+6.69%

1M Performance:

+18.73%

6M Performance:

-14.81%

1Y Performance:

-28.72%

1-Day Range:

$20.68

$21.64

1-Week Range:

$19.99

$21.64

52-Week Range:

$16.53

$41.02

Fortrea Holdings Inc Stock (FTRE) Company Profile

Name

Fortrea Holdings Inc

Sector

Healthcare (1180)

Industry

Biotechnology (675)

Phone

877-495-0816

Address

8 MOORE DRIVE, DURHAM

Employee

15,500

Twitter

Next Earnings Date

2024-11-08

Latest SEC Filings

FTRE's Discussions on Twitter

Compare FTRE with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
FTRE Fortrea Holdings Inc	21.05	1.89B	2.98B	-300.00M	225.00M	-3.40
VRTX Vertex Pharmaceuticals Inc	468.13	120.56B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	750.22	82.44B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	616.55	36.87B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	253.07	32.64B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	118.39	28.38B	3.30B	-501.07M	1.03B	-2.1146

Fortrea Holdings Inc Stock (FTRE) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-25-24	Downgrade	Jefferies	Buy → Hold
Aug-08-24	Downgrade	Evercore ISI	Outperform → In-line
Jul-24-24	Resumed	Barclays	Equal Weight
Jun-06-24	Initiated	Goldman	Neutral
May-29-24	Initiated	TD Cowen	Hold
May-28-24	Initiated	Mizuho	Neutral
Mar-22-24	Initiated	Robert W. Baird	Neutral
Mar-06-24	Initiated	Deutsche Bank	Hold
Jan-05-24	Initiated	William Blair	Mkt Perform
Jan-04-24	Initiated	Jefferies	Buy
Dec-11-23	Upgrade	Citigroup	Neutral → Buy
Dec-01-23	Upgrade	Evercore ISI	In-line → Outperform
Nov-14-23	Upgrade	Barclays	Equal Weight → Overweight
Oct-19-23	Initiated	Citigroup	Neutral
Sep-14-23	Initiated	Evercore ISI	In-line
Aug-16-23	Initiated	Barclays	Equal Weight
Aug-07-23	Initiated	BofA Securities	Underperform

View All

Fortrea Holdings Inc Stock (FTRE) Latest News

05:36 AM

Healthcare of Ontario Pension Plan Trust Fund Increases Stake in Fortrea Holdings Inc. (NASDAQ:FTRE) - MarketBeat

05:36 AM

Nov 29, 2024

HBK Investments L P Has $8.88 Million Stake in Fortrea Holdings Inc. (NASDAQ:FTRE) - MarketBeat

Nov 29, 2024

Nov 28, 2024

Evercore ISI Group Downgrades Fortrea Holdings (FTRE) - MSN

Nov 28, 2024

Fortrea: Some Green Shoots After A Dismal Period (NASDAQ:FTRE) - Seeking Alpha

Nov 28, 2024

Fortrea Holdings Inc. (NASDAQ:FTRE) Receives $24.50 Average Target Price from Analysts - Defense World

Nov 28, 2024

Nov 27, 2024

Baupost Group LLC MA Sells 847,193 Shares of Fortrea Holdings Inc. (NASDAQ:FTRE) - MarketBeat

Nov 27, 2024

Research Analysts’ Recent Ratings Changes for Fortrea (FTRE) - Defense World

Nov 27, 2024

Nov 26, 2024

Fortrea to Present at the Citi Global Healthcare Conference - GlobeNewswire

Nov 26, 2024

Nov 25, 2024

Analysts Set Fortrea Holdings Inc. (NASDAQ:FTRE) Target Price at $24.50 - MarketBeat

Nov 25, 2024

Nov 24, 2024

Fortrea Holdings Inc. (NASDAQ:FTRE) Shares Bought by Natixis Advisors LLC - MarketBeat

Nov 24, 2024

Nov 22, 2024

Fortrea Holdings Inc. (NASDAQ:FTRE) is Sessa Capital IM L.P.'s 7th Largest Position - MarketBeat

Nov 22, 2024

Pacer Advisors Inc. Grows Holdings in Fortrea Holdings Inc. (NASDAQ:FTRE) - MarketBeat

Nov 22, 2024

Nov 21, 2024

There Is A Reason Fortrea Holdings Inc.'s (NASDAQ:FTRE) Price Is Undemanding - Simply Wall St

Nov 21, 2024

Nov 20, 2024

TD Cowen Initiates Coverage of Fortrea Holdings (FTRE) with Hold Recommendation - MSN

Nov 20, 2024

Nov 19, 2024

Principal Financial Group Inc. Trims Holdings in Fortrea Holdings Inc. (NASDAQ:FTRE) - Defense World

Nov 19, 2024

Nov 18, 2024

Mutual of America Capital Management LLC Acquires 40,748 Shares of Fortrea Holdings Inc. (NASDAQ:FTRE) - MarketBeat

Nov 18, 2024

Victory Capital Management Inc. Trims Holdings in Fortrea Holdings Inc. (NASDAQ:FTRE) - MarketBeat

Nov 18, 2024

Nov 17, 2024

Fortrea Holdings Inc. (NASDAQ:FTRE) Shares Sold by Amalgamated Bank - Defense World

Nov 17, 2024

Nov 15, 2024